![]() |
市场调查报告书
商品编码
1876695
新型甜味剂技术市场预测至2032年:按产品类型、成分、形态、分销管道、应用、最终用户和地区分類的全球分析Novel Sweetener Technologies Market Forecasts to 2032 - Global Analysis By Product Type, Source, Form, Distribution Channel, Application, End User and By Geography |
||||||
根据 Stratistics MRC 的一项研究,预计到 2025 年,全球新型甜味剂技术市场价值将达到 37 亿美元,到 2032 年将达到 65.4 亿美元,预测期内复合年增长率为 8.5%。
新型甜味剂技术正在革新产品配方,它们提供类似糖的口感,但热量更低,代谢更健康。精准发酵、酵素加工和可控生物转化等技术,使得阿洛酮糖、塔格糖和稀有糖等新型甜味剂的生产成为可能,这些甜味剂在烹饪和加工过程中表现出与糖类似的特性。研究人员也利用人工智慧驱动的风味科学和植物来源分子来改善口感并消除不良余韵。这些进展符合洁净标示的要求、糖尿病食品的需求以及包装食品整体减糖的趋势。随着监管政策的支持和生产能力的提升,创新甜味剂可望广泛应用于饮料、烘焙产品、乳製品替代品和功能性营养产品。
根据英联食品全球减糖应用团队称,在过去五到十年里,甜味剂品类发生了显着变化,这主要得益于消费者对洁净标示、低热量、永续替代品的需求,其中稀有糖、甜味蛋白和甜菊糖衍生物是关键创新。
人们越来越关注健康和保健
人们日益关注肥胖、第2型糖尿病和心臟病等慢性疾病,这推动了对更清洁、更健康的甜味剂的需求。由于传统糖和过时的人工甜味剂热量高、血糖反应高且含有合成化学物质,消费者逐渐远离它们。随着各国政府和国际卫生组织推广减糖指南,企业开始转向天然或生物来源的甜味剂,这些甜味剂口感与糖相似,但代谢风险较低。木兰果、高级甜菊糖苷和特殊糖等成分正被添加到主流配方中,以保持产品的甜度、质地和保质期,从而促进饮料、烘焙食品、零食和健康营养品的创新。
生产成本高,规模有限。
成本挑战极大地限制了新型甜味剂技术的应用。复杂的发酵生产线、微生物工程和纯化过程需要精密的设备、规范的设施和训练有素的人员。稀有糖和纯化甜菊糖苷衍生物的生产通常需要多道工序,从而增加了人事费用、能源和过滤成本。许多甜味剂的商业化生产规模仍然有限,导致其价格远高于蔗糖和低成本的人工甜味剂。因此,大型食品品牌不愿意使用昂贵的原料来更改配方,因为这会影响其利润率。中小企业面临的障碍更大,儘管消费者对更健康的选择需求强劲,但优质甜味剂在烘焙产品、饮料、乳製品替代品和零食中的应用仍然缓慢。
在洁净标示和天然产品领域不断拓展应用
向天然透明标籤的转变,为源自植物和发酵技术的先进甜味剂创造了巨大的机会。甜菊糖苷衍生物、罗汉果萃取物和稀有醣类满足了消费者对成分简单、人工添加剂更少的需求。品牌可以在保持甜度和产品性能的同时,重新配製广受欢迎的食品和饮料产品。随着法规对天然甜味剂的清晰标示要求日益严格,消费者的接受度也不断提高。这些选择有助于打造纯素、有机和无化学添加的产品定位,并在高端健康食品领域越来越受欢迎。洁净标示趋势正在加速零食、乳製品替代品、饮料和早餐食品的普及,为提供天然低热量甜味剂的公司创造了巨大的成长潜力。
来自低成本糖和人造甜味剂的竞争
新型甜味剂面临来自价格低廉、市场成熟的醣类和合成甜味剂的竞争。高果糖玉米糖浆、蔗糖素和阿斯巴甜等原料因其价格低廉、供应广泛且加工性能可靠而占据市场主导地位。许多生产商不愿意更换原料,因为配方调整需要进行测试、认证,并增加原料成本。在对价格敏感的市场中,消费者倾向于购买较便宜的产品,因此较健康的替代品普及速度缓慢。强大的供应链和成熟的糖生产商进一步巩固了传统甜味剂的地位。只要价格差异仍然显着,新型甜味剂在饮料、糖果、酥皮点心和包装食品等领域的渗透速度可能较为缓慢,尤其是在健康意识薄弱或收入水平较低的地区。
新冠疫情为新型甜味剂技术带来了挑战与机会。初期,工厂停工、运输限制以及发酵原料短缺导致生产延误和营运成本上升。由于消费者支出的不确定性和供应中断,许多品牌推迟了配方改良计划。同时,人们对文明病的日益关注促使消费者减少糖的摄取量,转而选择更健康、低热量的产品。机能饮料、运动营养品和糖尿病零食等线上销售的成长支撑了需求的逐步增加。随着全球供应链的恢復和食品公司重启创新研发,人们对天然甜味剂的兴趣日益浓厚,增强了其长期市场潜力。
预计在预测期内,天然糖苷细分市场将占据最大的市场份额。
由于天然糖苷植物来源、甜度高且易于标註,预计在预测期内,天然糖苷将占据最大的市场份额。纯化的甜菊糖分子和罗汉果成分广泛应用于饮料、零食、乳製品替代品和机能性食品中,因为它们提供零卡路里的甜味,并且符合天然成分的趋势。製造商在配方改良计划中倾向于使用糖苷,以避免使用合成化学物质,并支持洁净标示声明。加工技术的进步消除了苦味和金属味,提高了风味品质,使其更适用于大规模食品应用。广泛的监管认可和与各种配方的兼容性使其成为业内最受欢迎的选择。
预计微生物发酵领域在预测期内将呈现最高的复合年增长率。
由于其产量稳定、风味纯净且可进行商业化规模生产,微生物发酵领域预计将在预测期内保持最高的成长率。利用优化的微生物和可控的生物反应器,生产商无需依赖有限的农业资源即可生产稀有糖和新一代糖苷。此方法确保了甜度的一致性、减少的余味以及在食品加工中更佳的功能性。随着发酵製程成本效益的提高,越来越多的品牌开始在低热量饮料、蛋白质点心、乳製品替代品和糖尿病食品中使用此类甜味剂。该技术的灵活性、永续性优势和可预测的成分品质正在推动业界广泛采用,使发酵甜味剂成为市场中成长最快的细分领域。
预计在整个预测期内,北美将占据最大的市场份额,这主要得益于消费者对天然、低热量成分和减糖策略的浓厚兴趣。文明病的高发生率推动了包括饮料、烘焙点心、蛋白棒和即食零食在内的各种产品开发健康配方。该地区拥有支持性的法规,允许使用新一代甜味剂,使品牌能够轻鬆进行产品配方调整。先进的研究设施、生物技术公司和原料供应商的存在,促进了快速的规模化生产和创新。零售商和速食店中低糖产品的日益普及,也推动了消费者的接受度。凭藉强大的购买力和健康意识,北美将继续保持在主导地位。
预计亚太地区在预测期内将实现最高的复合年增长率,这主要得益于人们健康意识的增强、中产阶级的壮大以及对减少糖摄入量的日益增长的需求。由于对肥胖和糖尿病的担忧,中国、印度、日本和韩国等市场越来越倾向选择天然低热量甜味剂。製造商正在将甜菊糖、罗汉果糖和稀有醣类添加到饮料、零食和乳製品中,以在不增加热量的情况下提供甜味。对发酵和精炼技术以及大规模生产设施的投资,使得这些甜味剂更易于取得且更具成本效益。政府支持健康饮食的计划以及现代零售业的快速发展也推动了这些甜味剂的普及。这些因素共同作用,使亚太地区成为该市场成长最快的地区。
According to Stratistics MRC, the Global Novel Sweetener Technologies Market is accounted for $3.7 billion in 2025 and is expected to reach $6.54 billion by 2032 growing at a CAGR of 8.5% during the forecast period. Novel sweetener technologies are transforming product formulations by delivering sugar-like taste with lower calories and healthier metabolic profiles. Techniques such as precision fermentation, enzymatic processing, and controlled bioconversion are enabling production of options like allulose, tagatose, and rare glycosides that behave like sugar in cooking and processing. Researchers are also using AI-assisted flavor science and plant-based molecules to improve mouthfeel and eliminate unwanted aftertastes. These advancements align with clean-label expectations, diabetic-friendly foods, and sugar-reduction initiatives across packaged goods. With supportive regulatory pathways and rising manufacturing capacity, innovative sweeteners are poised to appear widely in drinks, bakery items, dairy substitutes, and functional nutritional products.
According to Ingredion's Global Sugar Reduction Applications team, the sweetener landscape has evolved significantly over the past 5-10 years, driven by consumer demand for clean-label, low-calorie, and sustainable alternatives. Rare sugars, sweet proteins, and stevia derivatives are leading innovations.
Rising health and wellness awareness
Increasing concern about chronic health issues, including obesity, Type-2 diabetes, and heart disease, continues to push demand for cleaner and healthier sweetening solutions. Consumers are rejecting traditional sugar and older artificial sweeteners due to calorie density, high glycemic response, and synthetic chemical exposure. As governments and global health organizations promote sugar reduction guidelines, companies are turning toward natural or biologically produced sweeteners that behave like sugar but carry fewer metabolic risks. Ingredients such as monk fruit, advanced stevia glycosides, and rare sugars are entering mainstream recipes to preserve sweetness, product texture, and shelf performance, supporting innovation across beverages, bakery items, snacks, and health-focused nutrition products.
High production costs and limited scale
Cost challenges significantly restrict the expansion of novel sweetener technologies. Advanced fermentation lines, microbial engineering, and purification stages demand sophisticated equipment, regulated facilities, and highly trained personnel. Producing rare sugars or refined stevia derivatives frequently requires multi-step processing, adding labor, energy, and filtration costs. Many sweeteners are still made at limited commercial scale, which keeps prices high compared to sucrose or low-cost artificial sweeteners. As a result, large food brands hesitate to shift recipes because reformulating with costly ingredients affects margins. Smaller companies face even greater obstacles, slowing wider use of premium sweeteners in baked goods, beverages, dairy alternatives, and snacks despite strong consumer demand for healthier options.
Growing application in clean-label and natural products
The shift toward natural and transparent labeling creates a large opportunity for advanced sweeteners sourced from plants or fermentation. Stevia derivatives, monk fruit compounds, and rare sugars align with consumer demand for simple ingredients and reduced artificial additives. Brands can reformulate popular foods and beverages while maintaining sweetness and product performance. As regulations increasingly allow clear labeling for natural sweeteners, customer acceptance improves. These options support vegan, organic, and chemical-free product positioning, making them popular in premium health categories. The clean-label trend is accelerating adoption across snacks, dairy alternatives, drinks, and breakfast foods, providing major growth potential for companies offering natural low-calorie sweeteners.
Competition from low-cost sugar and artificial sweeteners
New sweeteners must compete with inexpensive and well-established sugar and synthetic sweeteners. Ingredients such as high-fructose corn syrup, sucralose, and aspartame dominate due to low prices, wide availability, and proven processing value. Many manufacturers avoid switching because reformulation requires testing, certification, and higher ingredient costs. In cost-driven markets, consumers continue purchasing cheaper products, slowing adoption of healthier alternatives. Strong supply chains and mature sugar producers further strengthen the position of traditional sweeteners. As long as price gaps remain large, novel sweeteners may experience slow penetration in beverages, candies, pastries, and packaged food categories, particularly in regions with limited health awareness or lower income levels.
The Covid-19 pandemic produced both challenges and opportunities for novel sweetener technologies. In the early stages, factory shutdowns, transport restrictions, and shortages of fermentation inputs slowed production and raised operational costs. Many brands delayed reformulation projects due to uncertainty in consumer spending and supply disruptions. At the same time, rising awareness of lifestyle diseases encouraged people to cut back on sugar and switch to healthier, low-calorie options. Online sales of functional drinks, sports nutrition, and diabetic-friendly snacks expanded, supporting gradual demand growth. As global supply chains recovered and food companies restarted innovation pipelines, interest in natural sweeteners increased, reinforcing their long-term market potential.
The natural glycosides segment is expected to be the largest during the forecast period
The natural glycosides segment is expected to account for the largest market share during the forecast period as they deliver high sweetness potency while remaining plant-based and label-friendly. Refined stevia molecules and monk fruit components are used extensively in drinks, snacks, dairy alternatives, and functional foods because they offer sweetness without calories and align with natural ingredient preferences. Manufacturers favor glycosides for reformulation projects, as they avoid synthetic chemicals and support clean-label claims. Advances in processing have improved flavor quality by eliminating bitterness and metallic notes, increasing suitability for large-scale food applications. Their broad regulatory acceptance and compatibility with various formulations make them the most preferred option in the industry.
The microbial fermentation segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the microbial fermentation segment is predicted to witness the highest growth rate because it delivers reliable output, cleaner flavor, and commercial-scale manufacturing potential. Using optimized microorganisms and controlled bioreactors, producers can create rare sugars and next-generation glycosides without relying on limited agricultural sources. This method ensures consistent sweetness, reduced aftertaste, and improved functional behavior in food processing. As fermentation processes become more cost-efficient, brands are switching to these sweeteners for low-calorie beverages, protein snacks, dairy substitutes, and diabetic-friendly foods. The technology's flexibility, sustainability advantages, and predictable ingredient quality are driving strong industry adoption, positioning fermentation-based sweeteners as the fastest-expanding segment within the market.
During the forecast period, the North America region is expected to hold the largest market share, driven by strong interest in natural, low-calorie ingredients and sugar-reduction strategies. High rates of lifestyle-related diseases encourage companies to produce healthier formulations across drinks, baked foods, protein bars, and ready-to-eat snacks. The region benefits from supportive regulations that allow the use of next-generation sweeteners, making it easier for brands to reformulate products. Well-developed research facilities, biotech companies, and ingredient suppliers enable rapid scale-up and innovation. Retail and quick-service outlets increasingly offer reduced-sugar products, boosting consumer acceptance. With strong purchasing power and health awareness, North America continues to dominate this market segment.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rising health consciousness, expanding middle-class consumers, and interest in sugar reduction. Markets including China, India, Japan, and South Korea increasingly favor natural, low-calorie sweeteners to address obesity and diabetes concerns. Manufacturers are integrating stevia, monk fruit, and rare sugars into beverages, snacks, and dairy products to deliver sweetness without added calories. Investment in fermentation, purification, and large-scale production facilities makes these options more accessible and cost-efficient. Government programs supporting healthier diets and the rapid increase of modern retail strengthen adoption. These factors collectively make Asia-Pacific the region with the highest growth rate in this market.
Key players in the market
Some of the key players in Novel Sweetener Technologies Market include Cargill Inc., Archer Daniels Midland Company (ADM), Ingredion Incorporated, Tate & Lyle PLC, Ajinomoto Corporation Inc., Associated British Foods Plc, PureCircle, GLG Life Tech Corporation, Sweegen, Roquette Freres, BioNeutra Global Corporation, Stevia First Corporation, Koninklijke DSM N.V., BASF and Amyris, Inc.
In September 2025, Archer-Daniels-Midland Company has announced the signing of a definitive agreement to form a North American Animal Feed Joint Venture with Alltech. This strategic initiative is part of ADM's ongoing efforts to transition its animal nutrition business towards higher margin specialty ingredients.
In August 2025, Ingredion Inc. announced it has entered into a new five-year unsecured revolving credit agreement with JPMorgan Chase Bank, N.A., J.P. Morgan SE, and other lenders. The new credit facility allows Ingredion to borrow up to $1 billion at any time, with up to $25 million available as swingline loans and up to $50 million for letters of credit. The company also has the option to request additional revolving commitments or new term loan facilities for up to $750 million, subject to customary conditions.
In May 2025, Cargill Inc reached a settlement with fast-food giant McDonald's Corp. over its antitrust claims, which alleged price fixing by beef suppliers. The announcement stems from a lawsuit McDonald's filed in October 2024 against leading meatpackers Cargill, JBS, Swift Beef Co., National Beef Packing Co. and Tyson Foods claiming that they conspired to fix beef prices at artificially high levels by limiting beef supplies starting as early as 2015 through the time of the filing, in violation of the Sherman Act.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.